Daniel Matos

Management of dyslipidaemia in patients with coronary heart disease: Results from the ESC-EORP EUROASPIRE V survey in 27 countries

Guy De Backer, Piotr Jankowski, Kornelia Kotseva et al. · Atherosclerosis · 2019 · 369 citations · Full text

Medicine, Cardiology, Internal Medicine +14

The amount of late gadolinium enhancement outperforms current guideline-recommended criteria in the identification of patients with hypertrophic cardiomyopathy at risk of sudden cardiac death

P Freitas, A Ferreira, Edmundo Arteaga-Fernández et al. · Journal of Cardiovascular Magnetic Resonance · 2019 · 100 citations · Full text

Medicine, Cardiology, Radiology +17

Screening for Glucose Perturbations and Risk Factor Management in Dysglycemic Patients With Coronary Artery Disease—A Persistent Challenge in Need of Substantial Improvement: A Report From ESC EORP EUROASPIRE V

Giulia Ferrannini, Dirk De Bacquer, Guy De Backer et al. · Diabetes Care · 2020 · 79 citations · Full text

Medicine, Cardiology, Internal Medicine +15

Catheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy: a European observational multicentre study

António Creta, Perry Elliott, Mark J. Earley et al. · EP Europace · 2021 · 42 citations · Full text

Medicine, Cardiology, Cardiovascular Genetics +15

Pulsed-field ablation vs radiofrequency ablation for ventricular tachycardia: First in-human case of histologic lesion analysis

Pedro Adragão, Daniel Matos, Pedro Carmo et al. · Heart Rhythm · 2023 · 17 citations

Medicine, Cardiology, Clinical Cardiology +14